Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation

<b>Background:</b><i>Taraxacum officinale</i>(commonly known as dandelion) is a medicinal and edible plant, with the entire plant being used for therapeutic purposes. Studies have demonstrated that dandelion exhibits inhibitory effects against various types of cancer. However...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianing Liu, Hailing Yang, Ran Liu, Dongjin Sun, Yongbao Liu, Jing Lu, Jinbiao Liu, Junrui Lu
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/5/663
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850125963236474880
author Jianing Liu
Hailing Yang
Ran Liu
Dongjin Sun
Yongbao Liu
Jing Lu
Jinbiao Liu
Junrui Lu
author_facet Jianing Liu
Hailing Yang
Ran Liu
Dongjin Sun
Yongbao Liu
Jing Lu
Jinbiao Liu
Junrui Lu
author_sort Jianing Liu
collection DOAJ
description <b>Background:</b><i>Taraxacum officinale</i>(commonly known as dandelion) is a medicinal and edible plant, with the entire plant being used for therapeutic purposes. Studies have demonstrated that dandelion exhibits inhibitory effects against various types of cancer. However, research on its potential for lung cancer (LC) treatment is limited, and the specific compounds responsible for its anticancer effects, as well as the underlying mechanisms, remain unclear. <b>Methods</b>: This study aimed to elucidate the underlying pharmacological mechanisms by which dandelion exerts therapeutic effects against LC. Initially, active compounds of dandelion and their corresponding targets were retrieved from public databases. Subsequently, network pharmacology approaches were applied to identify LC-associated disease targets. By integrating drug-specific targets and disease-related targets, a comprehensive dandelion–lung cancer interaction network was established. Protein–protein interaction (PPI) analyses and functional enrichment studies were further performed to uncover potential molecular mechanisms. Additionally, molecular docking and molecular dynamics (MD) simulations were conducted to evaluate binding interactions between critical active constituents and core targets. To experimentally validate these findings, in vitro cellular assays combined with scanning electron microscopy (SEM) were employed to investigate the anticancer effects of taraxasterol, a key bioactive sterol compound isolated from dandelion, on LC cells. <b>Results</b>: Our analyses identified 58 active compounds in dandelion linked to 614 potential targets, of which 228 targets were associated with LC. The PPI network highlighted 16 core targets, notably TP53, CASP3 and EGFR. Functional enrichment analysis suggested that dandelion might exert its anticancer effects by modulating the tumor microenvironment through the regulation of these critical targets. Molecular docking results demonstrated stable binding interactions between major active compounds and the identified core targets. Furthermore, the anticancer activity of taraxasterol was experimentally validated through in vitro assays and SEM-based morphological assessments, confirming its inhibitory effects on A549 lung cancer cells. <b>Conclusions</b>: Collectively, our findings reveal a multi-targeted therapeutic mechanism of dandelion against LC and support its potential development as a novel natural candidate for lung cancer treatment.
format Article
id doaj-art-73a06b45eb4d4b54824c35b89c367cfd
institution OA Journals
issn 1424-8247
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-73a06b45eb4d4b54824c35b89c367cfd2025-08-20T02:34:01ZengMDPI AGPharmaceuticals1424-82472025-04-0118566310.3390/ph18050663Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental ValidationJianing Liu0Hailing Yang1Ran Liu2Dongjin Sun3Yongbao Liu4Jing Lu5Jinbiao Liu6Junrui Lu7School of Chemical Engineering and Technology, Tianjin University of Technology, Tianjin 300384, ChinaSchool of Chemical Engineering and Technology, Tianjin University of Technology, Tianjin 300384, ChinaSchool of Chemical Engineering and Technology, Tianjin University of Technology, Tianjin 300384, ChinaSchool of Chemical Engineering and Technology, Tianjin University of Technology, Tianjin 300384, ChinaSchool of Chemical Engineering and Technology, Tianjin University of Technology, Tianjin 300384, ChinaAnalysis and Testing Center, Tianjin University of Technology, Tianjin 300384, ChinaAnalysis and Testing Center, Tianjin University of Technology, Tianjin 300384, ChinaSchool of Chemical Engineering and Technology, Tianjin University of Technology, Tianjin 300384, China<b>Background:</b><i>Taraxacum officinale</i>(commonly known as dandelion) is a medicinal and edible plant, with the entire plant being used for therapeutic purposes. Studies have demonstrated that dandelion exhibits inhibitory effects against various types of cancer. However, research on its potential for lung cancer (LC) treatment is limited, and the specific compounds responsible for its anticancer effects, as well as the underlying mechanisms, remain unclear. <b>Methods</b>: This study aimed to elucidate the underlying pharmacological mechanisms by which dandelion exerts therapeutic effects against LC. Initially, active compounds of dandelion and their corresponding targets were retrieved from public databases. Subsequently, network pharmacology approaches were applied to identify LC-associated disease targets. By integrating drug-specific targets and disease-related targets, a comprehensive dandelion–lung cancer interaction network was established. Protein–protein interaction (PPI) analyses and functional enrichment studies were further performed to uncover potential molecular mechanisms. Additionally, molecular docking and molecular dynamics (MD) simulations were conducted to evaluate binding interactions between critical active constituents and core targets. To experimentally validate these findings, in vitro cellular assays combined with scanning electron microscopy (SEM) were employed to investigate the anticancer effects of taraxasterol, a key bioactive sterol compound isolated from dandelion, on LC cells. <b>Results</b>: Our analyses identified 58 active compounds in dandelion linked to 614 potential targets, of which 228 targets were associated with LC. The PPI network highlighted 16 core targets, notably TP53, CASP3 and EGFR. Functional enrichment analysis suggested that dandelion might exert its anticancer effects by modulating the tumor microenvironment through the regulation of these critical targets. Molecular docking results demonstrated stable binding interactions between major active compounds and the identified core targets. Furthermore, the anticancer activity of taraxasterol was experimentally validated through in vitro assays and SEM-based morphological assessments, confirming its inhibitory effects on A549 lung cancer cells. <b>Conclusions</b>: Collectively, our findings reveal a multi-targeted therapeutic mechanism of dandelion against LC and support its potential development as a novel natural candidate for lung cancer treatment.https://www.mdpi.com/1424-8247/18/5/663<i>Taraxacum officinale</i>taraxasterollung cancernetwork pharmacologymolecular dockingmolecular dynamics simulation
spellingShingle Jianing Liu
Hailing Yang
Ran Liu
Dongjin Sun
Yongbao Liu
Jing Lu
Jinbiao Liu
Junrui Lu
Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation
Pharmaceuticals
<i>Taraxacum officinale</i>
taraxasterol
lung cancer
network pharmacology
molecular docking
molecular dynamics simulation
title Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation
title_full Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation
title_fullStr Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation
title_full_unstemmed Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation
title_short Investigation of the Anti-Lung Cancer Mechanisms of <i>Taraxacum officinale</i> Based on Network Pharmacology and Multidimensional Experimental Validation
title_sort investigation of the anti lung cancer mechanisms of i taraxacum officinale i based on network pharmacology and multidimensional experimental validation
topic <i>Taraxacum officinale</i>
taraxasterol
lung cancer
network pharmacology
molecular docking
molecular dynamics simulation
url https://www.mdpi.com/1424-8247/18/5/663
work_keys_str_mv AT jianingliu investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT hailingyang investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT ranliu investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT dongjinsun investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT yongbaoliu investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT jinglu investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT jinbiaoliu investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation
AT junruilu investigationoftheantilungcancermechanismsofitaraxacumofficinaleibasedonnetworkpharmacologyandmultidimensionalexperimentalvalidation